Enovis Corporation (ENOV)
Healthcare • Medical Devices
StockNYSEUnited StatesUS1940145022
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Enovis Corporation, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 15:30. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 25 Feb 2027 08:00 | 1.03 | — | — | Upcoming |
| 05 Nov 2026 06:00 | 0.77 | 0.88 | +14.8% | Beat |
| 06 Aug 2026 06:00 | 0.85 | 0.90 | +6.3% | Beat |
| 07 May 2026 06:00 | 0.81 | 0.89 | +9.9% | Beat |
| 26 Feb 2026 06:00 | 0.84 | 0.95 | +13.1% | Beat |
| 06 Nov 2025 06:00 | 0.65 | 0.75 | +15.6% | Beat |
| 07 Aug 2025 06:00 | 0.72 | 0.79 | +9.9% | Beat |
| 08 May 2025 06:00 | 0.74 | 0.81 | +8.9% | Beat |
| 26 Feb 2025 06:00 | 0.92 | 0.98 | +7.0% | Beat |
| 06 Nov 2024 06:00 | 0.61 | 0.73 | +18.9% | Beat |
| 07 Aug 2024 06:00 | 0.59 | 0.62 | +4.5% | Beat |
| 02 May 2024 06:00 | 0.48 | 0.50 | +3.4% | Beat |
| 22 Feb 2024 06:00 | 0.74 | 0.79 | +6.8% | Beat |
| 07 Nov 2023 06:00 | 0.54 | 0.56 | +4.0% | Beat |
| 03 Aug 2023 06:00 | 0.52 | 0.61 | +18.5% | Beat |
| 04 May 2023 06:00 | 0.38 | 0.44 | +16.8% | Beat |
| 23 Feb 2023 06:00 | 0.66 | 0.72 | +9.9% | Beat |
| 02 Nov 2022 06:00 | 0.48 | 0.59 | +22.9% | Beat |
| 04 Aug 2022 06:00 | 0.50 | 0.59 | +18.0% | Beat |
| 10 May 2022 07:00 | 0.35 | 0.37 | +5.7% | Beat |
| 22 Feb 2022 06:00 | 1.74 | 1.77 | +2.0% | Beat |
| 04 Nov 2021 06:00 | 1.61 | 1.62 | +0.4% | In line |
| 28 Jul 2021 16:00 | 1.61 | 1.68 | +4.5% | Beat |
| 29 Apr 2021 06:00 | 1.19 | 1.32 | +10.6% | Beat |
| 18 Feb 2021 06:00 | 1.51 | 1.53 | +1.6% | Beat |
| 29 Oct 2020 06:00 | 1.17 | 1.23 | +4.9% | Beat |
| 06 Aug 2020 06:00 | 0.18 | 0.27 | +47.1% | Beat |
| 07 May 2020 07:00 | 1.11 | 1.14 | +2.7% | Beat |
| 21 Feb 2020 06:00 | 1.67 | 1.83 | +9.3% | Beat |
| 31 Oct 2019 06:00 | 1.42 | 1.50 | +5.4% | Beat |
| 06 Aug 2019 06:00 | 1.84 | 1.62 | -12.2% | Miss |
| 08 May 2019 06:00 | 1.48 | 1.59 | +7.6% | Beat |
| 13 Feb 2019 06:00 | 1.90 | 2.07 | +9.1% | Beat |
| 25 Oct 2018 05:00 | 1.58 | 1.62 | +2.5% | Beat |
| 06 Aug 2018 06:00 | 1.56 | 1.83 | +17.2% | Beat |
| 03 May 2018 06:00 | 1.28 | 1.44 | +12.9% | Beat |
| 06 Feb 2018 06:00 | 1.29 | 1.35 | +4.8% | Beat |
| 06 Nov 2017 06:00 | 1.23 | 1.26 | +2.2% | Beat |
| 28 Jul 2017 06:00 | 1.29 | 1.29 | -0.2% | In line |
| 05 May 2017 06:00 | 0.89 | 1.05 | +17.7% | Beat |
| 02 Feb 2017 06:00 | 1.32 | 1.38 | +4.9% | Beat |
| 27 Oct 2016 05:00 | 1.04 | 1.17 | +12.6% | Beat |
| 28 Jul 2016 06:00 | 1.16 | 1.23 | +6.0% | Beat |
| 03 May 2016 05:00 | 0.81 | 0.90 | +11.3% | Beat |
| 04 Feb 2016 06:00 | 1.29 | 1.53 | +18.3% | Beat |
| 14 Oct 2015 06:00 | 1.22 | 0.72 | -41.0% | Miss |
| 23 Jul 2015 06:00 | 1.42 | 1.50 | +5.3% | Beat |
| 23 Apr 2015 06:00 | 1.00 | 1.08 | +8.2% | Beat |
| 05 Feb 2015 06:00 | 1.90 | 2.16 | +13.5% | Beat |
| 23 Oct 2014 06:00 | 1.83 | 1.71 | -6.7% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 2.2B | +6.7% | -1.2B | -52.7% | -20.75 | -39.0% | 19.9M |
| 2024 | 2.1B | +23.5% | -825.5M | -39.2% | -14.93 | -2,347.5% | -67.2M |
| 2023 | 1.7B | +9.2% | -33.3M | -1.9% | -0.61 | -144.0% | 12.8M |
| 2022 | 1.6B | — | -13.3M | -0.9% | -0.25 | — | -161.3M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 20.37 | 29.89 | 20.34 | 28.03 | +40.78% | 21,705,631 | |
| Oct 2026 | 18.19 | 22.84 | 16.70 | 19.91 | +8.98% | 30,824,900 | |
| Sep 2026 | 24.49 | 24.55 | 17.30 | 18.27 | -25.70% | 47,126,500 | |
| Aug 2026 | 29.93 | 31.67 | 23.63 | 24.59 | -15.64% | 22,556,100 | |
| Jul 2026 | 21.01 | 30.53 | 19.86 | 29.15 | +40.82% | 23,746,400 | |
| Jun 2026 | 22.22 | 24.58 | 19.14 | 20.70 | -8.73% | 25,267,200 | |
| May 2026 | 23.62 | 27.89 | 22.51 | 22.68 | -3.24% | 24,073,700 | |
| Apr 2026 | 22.81 | 27.04 | 22.14 | 23.44 | +3.03% | 17,029,500 | |
| Mar 2026 | 24.62 | 26.01 | 21.40 | 22.75 | -10.68% | 20,805,600 | |
| Feb 2026 | 21.97 | 26.41 | 21.15 | 25.47 | +15.56% | 23,286,700 | |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- ENOV Q3 2026 deep dive: product innovation and share gains amid market volatility (opens in a new tab) StockStory · 10 Nov 2026 12:13
- Enovis Stock Earnings Beat Raises Full Year Outlook (opens in a new tab) Simply Wall St. · 07 Nov 2026 11:13
- What Enovis (ENOV) Said on Its Q3 Earnings Call (opens in a new tab) MarketBeat · 07 Nov 2026 07:17
- Canaccord Genuity Maintains Buy on Enovis, Lowers Price Target to $42 (opens in a new tab) Benzinga · 06 Nov 2026 15:46
- Evercore ISI Group Maintains Outperform on Enovis, Raises Price Target to $33 (opens in a new tab) Benzinga · 06 Nov 2026 10:44
- Wells Fargo Maintains Overweight on Enovis, Raises Price Target to $37 (opens in a new tab) Benzinga · 06 Nov 2026 10:43
- Enovis Corporation (ENOV) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 06 Nov 2026 07:04
- Enovis Corporation 2026 Q3 - Results - Earnings Call Presentation (opens in a new tab) SeekingAlpha · 06 Nov 2026 04:03
- Enovis Corp (ENOV) Q3 2026 Earnings Call Highlights: Organic Growth of 5%, Raised Guidance, and ... (opens in a new tab) GuruFocus.com · 05 Nov 2026 23:17
- Enovis Corporation Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 05 Nov 2026 23:13
- Enovis Corp (ENOV) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 05 Nov 2026 20:17
- Needham Maintains Buy on Enovis, Raises Price Target to $38 (opens in a new tab) Benzinga · 05 Nov 2026 17:44
- Enovis Corporation Reports Third Quarter 2026 Results and Announces New $200 million Share Repurchase Authorization (opens in a new tab) Fintel · 05 Nov 2026 14:52
- BTIG Maintains Buy on Enovis, Raises Price Target to $42 (opens in a new tab) Benzinga · 05 Nov 2026 13:50
- Enovis’s (NYSE:ENOV) Q3 2026 earnings results: revenue in line with expectations, stock soars (opens in a new tab) StockStory · 05 Nov 2026 11:47
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 27.64 USD
- Market cap
- 1.6B
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Medical Devices
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow ENOV and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.